Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

Object Details

• Location: Deutsche Nationalbibliothek Frankfurt am Main
• Extent: 1 Online-Ressource.
• Language: Englisch

References and Relationships

• Bibliographic citation: Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study ; volume:18 ; number:1 ; day:21 ; month:10 ; year:2023 ; pages:1-12 ; date:12.2023 ; Orphanet journal of rare diseases ; 18, Heft 1 (21.10.2023), 1-12, 12.2023

Contributors, Places and Time

• Creator: Linhart, Aleš ; Dostálová, Gabriela ; Nicholls, Kathy ; West, Michael L. ; Tøndel, Camilla ; Jovanovic, Ana ; Giraldo, Pilar ; Vujkovac, Bojan ; Geberhiwot, Tarekegn ; Brill-Almon, Einat ; Alon, Sari ; Chertkoff, Raul ; Rocco, Rossana ; Hughes, Derralynn
• Contributor: SpringerLink (Online service)

Further information

• DOI: 10.1186/s13023-023-02937-6
• URN: urn:nbn:de:101:1-2024020907434462252655
• Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Last update: 15.08.2025, 7:32 AM CEST